A human trial of Abeliophyllum distichum Nakai. leaf extract on decrease of body fat
- Conditions
- Endocrine, nutritional and metabolic diseases
- Registration Number
- KCT0008832
- Lead Sponsor
- Wonkwang University. Iksan Korean Medicine Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
1) Adult men and women aged 19 years or older and 65 years or younger at the screening test
2) A person with a BMI of 25 to 34.9 kg/m^2 at the screening test, and a body fat percentage of 25% or more for men and 30% or more for women
1) If you have been taking any product that affects your weight within 1 month prior to screening test
2) Those who have undergone obesity surgery within the last 1 year
3) Those with clinically significant acute or chronic cardiovascular, endocrine, immune, respiratory, hepatobiliary, renal and urinary system, neuropsychiatric, musculoskeletal, inflammatory and gastrointestinal diseases requiring treatment
4) Diabetic patients taking oral hypoglycemic agents or insulin at the time of screening
5) Those who have a history of clinically significant hypersensitivity to the components of leaves of Abeliophyllum distichum Nakai. (However, according to the judgment of the principal investigator, patients may participate in this study considering the condition of the research subject.)
6) Those with alcohol intake of 14 units/week or more
7) Those who have received antipsychotic drug treatment within 3 months prior to screening
8) Those who have or are suspected of drug abuse
9) Those who participated in other human tirals within 3 months before the screening test
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body Fat Mass and Body Fat Percentage
- Secondary Outcome Measures
Name Time Method anthropometric index;lipid metabolism index;lean body mass;Abdominal fat index